TURRINI, MAURO
TURRINI, MAURO
Dipartimento di Scienze della Salute
Nanoplastics perturb extracellular vesicle-mediated communication in the in vitro and ex vivo bone marrow microenvironment of multiple myeloma
2026 A. Villa, V. Citro, G. Sauro, P. Ciana, R. Chiaramonte, D. Giannandrea, N. Platonova, E. Lesma, C. Bernardelli, B. De Felice, M. Turrini, F. Guidotti, M. Chiu, M. Parolini, L. Casati
Bone Marrow CD34+/lin- Cells of Patients with Chronic-Phase Chronic Myeloid Leukemia (CP-CML) After 12 Months of Nilotinib Treatment Exhibit a Different Gene Expression Signature Compared to the Diagnosis and the Corresponding Cells from Healthy Subjects
2025 A. Trojani, E. Pungolino, B. Di Camillo, L.E. Bossi, C. Palumbo, M. D'Adda, A. Perego, M. Turrini, C. Elena, L.M. Borin, A. Iurlo, S. Malato, F. Spina, M.L. Latargia, P. Spedini, S. Artale, M. Anghilieri, M.C. Carraro, C. Bucelli, A. Beghini, R. Cairoli
Adapting the Fitness Criteria for Non-Intensive Treatments in Older Patients with Acute Myeloid Leukemia to the Use of Venetoclax-Hypomethylating Agents Combination—Practical Considerations from the Real-Life Experience of the Hematologists of the Rete Ematologica Lombarda
2024 G. Rossi, E. Borlenghi, P. Zappasodi, F. Lussana, M. Bernardi, C. Basilico, A. Molteni, I. Lotesoriere, M. Turrini, M. Frigeni, M. Fumagalli, P. Cozzi, F. Gigli, C. Cattaneo, N.S. Fracchiolla, M. Riva, G. Martini, V. Mancini, R. Cairoli, E. Todisco
Real‐world efficacy and safety of luspatercept and predictive factors of response in patients with lower risk myelodysplastic syndromes with ring sideroblasts
2023 L. Lanino, F. Restuccia, A. Perego, M. Ubezio, B. Fattizzo, M. Riva, A. Consagra, P. Musto, D. Cilloni, E.N. Oliva, R. Palmieri, A. Poloni, C. Califano, I. Capodanno, F. Itri, C. Elena, C. Fozza, F. Pane, A.M. Pelizzari, M. Breccia, F. Di Bassiano, E. Crisà, D. Ferrero, V. Giai, D. Barraco, A. Vaccarino, D. Griguolo, P. Minetto, M. Quintini, S. Paolini, G. Sanpaolo, M. Sessa, M. Bocchia, N. Di Renzo, E. Diral, L. Leuzzi, A. Genua, A. Guarini, A. Molteni, B. Nicolino, U. Occhini, G. Rivoli, R. Bono, A. Calvisi, A. Castelli, E. Di Bona, A. Di Veroli, F. Ferrara, L. Fianchi, S. Galimberti, D. Grimaldi, M. Marchetti, M. Norata, M. Frigeni, R. Sancetta, C. Selleri, I. Tanasi, P. Tosi, M. Turrini, L. Giordano, C. Finelli, P. Pasini, I. Naldi, V. Santini, M.G. Della Porta, N. Null
Neutralizing monoclonal antibodies in haematological patients paucisymptomatic for COVID-19: The GIMEMA EMATO-0321 study
2022 V. Marasco, A. Piciocchi, A. Candoni, L. Pagano, A. Guidetti, P. Musto, R. Bruna, M. Bocchia, A. Visentin, M. Turrini, A. Tucci, S. Pilerci, L. Fianchi, M. Salvini, S. Galimberti, E. Coviello, C. Selleri, M. Luppi, E. Crea, P. Fazi, F. Passamonti, P. Corradini
A prognostic model for patients with lymphoma and COVID-19: a multicentre cohort study
2022 C. Visco, L. Marcheselli, R. Mina, M. Sassone, A. Guidetti, D. Penna, C. Cattaneo, V. Bonuomo, A. Busca, A.J.M. Ferreri, R. Bruna, L. Petrucci, R. Cairoli, M. Salvini, L. Bertù, M. Ladetto, S. Pilerci, A. Pinto, S. Ramadan, F. Marchesi, M. Cavo, L. Arcaini, E. Coviello, A. Romano, P. Musto, M. Massaia, N.S. Fracchiolla, M. Marchetti, A. Scattolin, M.C. Tisi, A. Cuneo, M.G. Della Porta, L. Trentin, M. Turrini, F. Gherlinzoni, A. Tafuri, S. Galimberti, M. Bocchia, V. Cardinali, D. Cilloni, A. Corso, D. Armiento, L. Rigacci, E. Ortu La Barbera, C.B. Gambacorti-Passerini, G. Visani, D. Vallisa, A. Venditti, C. Selleri, A. Conconi, P. Tosi, F. Lanza, A. Candoni, M. Krampera, P. Corradini, F. Passamonti, F. Merli
Safety and Efficacy of Subcutaneous Rituximab in Previously Untreated Patients with CD20+ Diffuse Large B-Cell Lymphoma or Follicular Lymphoma: Results from an Italian Phase IIIb Study
2022 M. Petrini, G. Gaidano, A. Mengarelli, U. Consoli, A. Santoro, A.M. Liberati, M. Ladetto, V. Fraticelli, A. Guarini, D. Mannina, P. Ferrando, P. Corradini, P. Musto, C. Stelitano, D. Marino, A. Camera, M. Murineddu, R. Battistini, G. Caparrotti, M. Turrini, L. Arcaini, S. Santini, M. Cerqueti, A.J.M. Ferreri, N. Cantore, A. Inzoli, G. Cardinale, B. Ronci, G. La Nasa, S. Massimi, G. Gaglione, V. Barbiero, M. Martelli
Secondary infections worsen the outcome of COVID-19 in patients with hematological malignancies: A report from the ITA-HEMA-COV
2022 P. Zappasodi, C. Cattaneo, V. Valeria Ferretti, R. Mina, A. José María Ferreri, F. Merli, M. Oberti, M. Krampera, A. Romano, C. Zerbi, J. Ferrari, M. Cavo, M. Salvini, L. Bertù, N. Stefano Fracchiolla, F. Marchesi, M. Massaia, V. Marasco, R. Cairoli, A. Maria Scattolin, A. Maria Vannucchi, C. Gambacorti-Passerini, P. Musto, F. Gherlinzoni, A. Cuneo, A. Pinto, L. Trentin, M. Bocchia, S. Galimberti, E. Coviello, M. Chiara Tisi, A. Morotti, B. Falini, M. Turrini, A. Tafuri, A. Billio, M. Gentile, R. Massimo Lemoli, A. Venditti, M. Giovanni Della Porta, F. Lanza, L. Rigacci, P. Tosi, S. Mohamed, A. Corso, M. Luppi, N. Giuliani, A. Busca, L. Pagano, R. Bruno, P. Antonio Grossi, P. Corradini, F. Passamonti, L. Arcaini
The role of NOTCH2 in the Extracellular vesicles mediated communication in Multiple Myeloma: a focus on angiogenesis and osteoclastogenesis
2021 D. Giannandrea, N. Platonova, M. Colombo, V. Citro, R. Adami, F. Maltoni, S. Ancona, A. Basile, L. Cantone, V. Bollati, L. Casati, M. Turrini, E. Lesma, R. Chiaramonte
The role of NOTCH2 in the extracellular vesicles-mediated angiogenesis and osteoclastogenesis in multiple myeloma
2021 D. Giannandrea, N. Platonova, V. Citro, M. Colombo, M. Mazzola, R. Adami, F. Maltoni, L. Cantone, A. Pistocchi, V. Bollati, S. Ancona, E. Lesma, M. Turrini, R. Chiaramonte
The role of Notch pathway in the pro-tumorigenic activity of extracellular vesicles in multiple myeloma
2021 D. Giannandrea, M. Colombo, N. Platonova, V. Citro, M. Mazzola, A. Pistocchi, R. Adami, V. Dolo, I. Giusti, L. Cantone, V. Bollati, M. Turrini, R. Chiaramonte
Multiple myeloma exploits Jagged1 and Jagged2 to promote intrinsic and bone marrow-dependent drug resistance
2020 M. Colombo, S. Garavelli, M. Mazzola, N. Platonova, D. Giannandrea, R. Colella, L. Apicella, M. Lancellotti, E. Lesma, S. Ancona, M.T. Palano, M. Barbieri, E. Taiana, E. Lazzari, A. Basile, M. Turrini, A. Pistocchi, A. Neri, R. Chiaramonte
Targeting extracellular vesicles in multiple myeloma: a new role for the Notch pathway
2019 D. Giannandrea, M. Colombo, N. Platonova, M. Mazzola, F. Baccianti, R. Adami, L. Cantone, E. Milano, A. Pistocchi, V. Bollati, S. Ancona, E. Lesma, M. Turrini, R. Chiaramonte
Secondary acute myeloid leukaemia in elderly patients : Patient's fitness criteria and ELN prognostic stratification can be applied to guide treatment decisions : an analysis of 280 patients by the network rete ematologica lombarda (REL)
2018 E. Borlenghi, C. Pagani, P. Zappasodi, M. Bernardi, C. Basilico, E. Todisco, N. Fracchiolla, V. Mancini, M. Turrini, M. Da Vià, E. Sala, C. Cattaneo, M. Petullà, F. Serana, A. Ferrario, R. Cairoli, A. Cortelezzi, A. Santoro, C. Castagnola, G. Rossi
Corrigendum: Intronless WNT10B-short variant underlies new recurrent allele-specific rearrangement in acute myeloid leukaemia (Scientific Reports (2017) 6 (37201) DOI: 10.1038/srep37201)
2017 F. Lazzaroni, L. Del Giacco, D. Biasci, M. Turrini, L. Prosperi, R. Brusamolino, R. Cairoli, A. Beghini
Clinical relevance of recurrent allele-specific recombination expressing the WNT10Bivs1 allele variant in acute myeloid leukemia
2016 A. Beghini, F. Lazzaroni, L. Del Giacco, O. Soderberg, D. Biasci, M. Turrini, L. Prosperi, R. Brusamolino, U. Landegren, R. Cairoli
Clinical relevance of WNT10B / WNT10BIVS1 allele variant expression and its potential in Acute Myeloid Leukemia risk assessment
2016 M. Turrini
Old and new prognostic factors in acute myeloid leukemia with deranged core-binding factor beta.
2013 R. Cairoli, A. Beghini, M. Turrini, G. Bertani, G. Nadali, F. Rodeghiero, C. Castagnola, F. Lazzaroni, M. Nichelatti, F. Ferrara, G. Pizzolo, E. Pogliani, G. Rossi, G. Martinelli, E. Morra